Results 181 to 190 of about 10,108,350 (409)
Labor Market Outcomes of Immigrants and Non-Citizens in the EU: An East-West Comparison [PDF]
The starkly different histories and institutions in the eastern and western member states of the European Union (EU) suggest different roles of being non-native in these two regions.
Kahanec, Martin, Zaiceva, Anzelika
core
Molecular Oncology, EarlyView.CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Ms. Foundation for Women, 2011 Annual Report [PDF]
, 2012 Energized by New York, the Ms. Foundation is helping transform a regional win into victory nationwide. We were there to support DWU as it led the formation of the National Domestic Workers Alliance (NDWA), a coalition that now boasts 31 member groups ...
core
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Molecular Oncology, EarlyView.Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
SOCIAL DEVELOPMENT OF RURAL AREAS IN THE EUROPEAN UNION MEMBER STATES IN 2000-2012
, 2015 Mariana Vashchyk, Tomasz Siudek
openalex +2 more sources
Molecular Oncology, EarlyView.HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source